Perioperative use of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists

Journal of Clinical Anesthesia

Volumn 40, Issue , 2017, Pages 91-98

  Vaquero Roncero, Luis Mario ^a   Sánchez Poveda, David ^a   Valdunciel García, Joaquín José ^a   Sánchez Barrado, María Elisa ^a   Calvo Vecino, José María ^a  

^a Universidad de Salamanca   (Spain)

Author keywords

Angiotensin receptor antagonists; Angiotensin converting enzyme inhibitors; Perioperative care therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANESTHESIA; ANESTHESIA COMPLICATION; ARTERIAL PRESSURE; COMORBIDITY; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; HUMAN; HYPOTENSION; MORBIDITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL ANESTHESIA; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; DRUG ADMINISTRATION; METHODOLOGY; PEROPERATIVE COMPLICATION; PROCEDURES;

ANESTHESIA; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOTENSION; INTRAOPERATIVE COMPLICATIONS; PERIOPERATIVE CARE; RESEARCH DESIGN;

EID: 85018377538     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2017.04.018     Document Type: Review

References (49)

1. [1] Matchar, D.B., McCrory, D.C., Orlando, L.A., Patel, M.R., Patel, U.D., Patwardhan, M.B., et al. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann. Intern. Med. 148:1 (Jan 1 2008), 16–29.
2. [2] Sear, J.W., Perioperative renin-angiotensin blockade: to continue or discontinue, that is the question!. Anesth. Analg. 118:5 (May 2014), 909–911.
3. [3] Colson, P., Ryckwaert, F., Coriat, P., Renin angiotensin system antagonists and anesthesia. Anesth. Analg. 89:5 (Nov 1999), 1143–1155 [Review].
4. [4] Vaquero Roncero, L.M., Julián González, R., Muriel, Villoria C., Refractory hypotension during anesthesia in a patient treated with angiotensin receptor blockers. Rev. Esp. Anestesiol. Reanim. 51:6 (Jun–Jul 2004), 338–341.
5. [5] Barber, L., Barrio, J., de Rojas, M.D., Ibañez, F., Añó, C., Alepuz, R., et al. Refractory hypotension sustained during general anesthesia due to chronic treatment with angiotensin-converting enzyme inhibitors. Rev. Esp. Anestesiol. Reanim. 48:1 (Jan 2001), 34–37.
6. [6] Smith, I., Jackson, I., Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anesthesia?. Curr. Opin. Anaesthesiol. 23:6 (Dec 2010), 687–690.
7. [7] Auron, M., Harte, B., Kumar, A., Michota, F., Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice. Postgrad. Med. J. 87:1029 (Jul 2011), 472–481.
8. [8] Castanheira, L., Fresco, P., Macedo, A.F., Guidelines for the management of chronic medication in the perioperative period: systematic review and formal consensus. J. Clin. Pharm. Ther. 36:4 (Aug 2011), 446–467.
9. [9] Hollevoet, I., Herregods, S., Vereecke, H., Vandermeulen, E., Herregods, L., Medication in the perioperative period: stop or continue? A review. Acta Anaesthesiol. Belg. 62:4 (2011), 193–201.
10. [10] Lonjaret, L., Lairez, O., Minville, V., Geeraerts, T., Optimal perioperative management of arterial blood pressure. Integr. Blood Press. Control 7:12 (Sep 2014), 49–59.
11. [11] Société française d'anesthésie et de réanimation, Perioperative assessment of cardiac risk patient in non-cardiac surgery. Ann. Fr. Anesth. Reanim. 30 (2011), e5–e29.
12. [12] García-Miguel, F.J., Peyró, R., Mirón Rodríguez, M.F., Valoración anestésica preoperatoria y preparación del paciente quirúrgico. Rev. Esp. Anestesiol. Reanim. 60:Supl 1 (2013), 11–26.
13. [13] Muluk, V., Macpherson, D.S., Perioperative medication management. (Up To Date Review). Up To Date, 19, 2010, 1 [accessed 6-2011]. Available at: http://www.uptodate.com.
14. [14] Grupo de Trabajo Conjunto sobre cirugía no cardiaca: evaluación y manejo cardiovascular de la Sociedad Europea de Cardiología (ESC) y la European Society of Anesthesiology (ESA), Guía de práctica clínica de la ESC/ESA 2014 sobre cirugía no cardiaca: evaluación y manejo cardiovascular. Rev. Esp. Cardiol. 67:12 (2014), 1052.e1–1052.e43.
15. [15] Fleisher, L.A., Fleischmann, K.E., Auerbach, A.D., Barnason, S.A., Beckman, J.A., Bozkurt, B., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130:24 (Dec 9 2014), e278–e333.
16. [16] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., The PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med., 6(7), 2009, e1000097 https://doi.org/10.1371/journal.pmed.1000097.
17. [17] Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J.M., Gavaghan, D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Contr. Clin.Trials 17:1 (1996), 1–12.
18. [18] Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses. Available from: http://www.medicine.mcgill.ca/rtamblyn/Readings.TheNewcastleScaleforassessingthequalitynonrandomizedstudiesinmeta-analyses.pdf, 2010.
19. [19] McCarthy, G.J., Hainsworth, M., Lindsay, K., Writght, J.M., Brown, T.A., Pressor responses to tracheal intubation after sublingual captopril. A pilot study. Anaesthesia 45 (1990), 243–245.
20. [20] Coriat, P., Richer, C., Douraki, T., Gómez, C., Hendricks, K., Giudicelli, J.F., et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 81 (1994), 299–307.
21. [21] Brabant, S.M., Bertrand, M., Eyraud, D., Darmon, P.L., Coriat, P., The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth. Analg. 89 (1999), 1388–1392.
22. [22] Bertrand, M., Godet, G., Meersschaert, K., Brun, L., Salcedo, E., Coriat, P., Should the angiotensin II antagonists be discontinued before surgery?. Anesth. Analg. 92 (2001), 26–30.
23. [23] Comfere, T., Sprung, J., Kumar, M.M., Draper, M., Wilson, D.P., Williams, B.A., et al. Angiotensin system inhibitors in a general surgical population. Anesth. Analg. 100 (2005), 636–644.
24. [24] Schirmer, U., Schurmann, W., Preoperative administration of angiotensin-converting enzyme inhibitors. Anaesthesist 56 (2007), 557–561.
25. [25] Kheterpal, S., Khodaparast, O., Shanks, A., O'Reilly, M., Tremper, K.K., Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J. Cardiothorac. Vasc. Anesth. 22:2 (Apr 2008), 180–186.
26. [26] Rajgopal, R., Rajan, S., Sapru, K., Paul, J., Effect of pre-operative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists on intra-operative arterial pressures after induction of general anesthesia. Anesth. Essays Res. 8:1 (Jan–Apr 2014), 32–35.
27. [27] Twersky, R.S., Goel, V., Narayan, P., Weedon, J., The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients. Anesth. Analg. 118:5 (May 2014), 938–944.
28. [28] Brabant, S.M., Eyraud, D., Bertrand, M., Coriat, P., Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists. Anesth. Analg. 89:4 (Oct 1999), 887–888.
29. [29] Eyraud, D., Brabant, S., Nathalie, D., Fléron, M.H., Gilles, G., Bertrand, M., et al. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth. Analg. 88:5 (May 1999), 980–984.
30. [30] Boccara, G., Ouattara, A., Godet, G., Dufresne, E., Bertrand, M., Riou, B., et al. Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors. Anesthesiology 98:6 (Jun 2003), 1338–1344.
31. [31] Mackay, J.H., Walker, I.A., Bethune, D.W., Amiodarone and anaesthesia: concurrent therapy with ACE inhibitors — an additional cause for concern?. Can. J. Anaesth., 38, 1991, 687.
32. [32] Sear, J.W., Jewkes, C., Tellez, J.C., Foëx, P., Does the choice of antihypertensive therapy influence haemodynamic responses to induction, laryngoscopy and intubation?. Br. J. Anaesth. 73:3 (Sep 1994), 303–308.
33. [33] Reich, D.L., Hossain, S., Krol, M., Baez, B., Patel, P., Bernstein, A., et al. Predictors of hypotension after induction of general anesthesia. Anesth. Analg. 101 (2005), 622–628.
34. [34] Da Costa, V.V., Caldas, A.C., Nunes, L.G., Beraldo, P.S., Saraiva, R.A., Influence of angiotensin-converting enzyme inhibitors on hypotension after anesthetic induction: is the preoperative discontinuation of this drug necessary. Rev. Bras. Anestesiol. 59:6 (Nov–Dec 2009), 704–715.
35. [35] Turan, A., You, J., Shiba, A., Kurz, A., Saager, L., Sessler, D.I., Angiotensin-converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth. Analg. 114:3 (Mar 2012), 552–560.
36. [36] Salvetti, G., Di Salvo, C., Ceccarini, G., Abramo, A., Fierabracci, P., Magno, S., et al. Chronic renin-angiotensin system (RAS) blockade may not induce hypotension during anaesthesia for bariatric surgery. Obes. Surg. 26:6 (Jun 2016), 1303–1307.
37. [37] Cittanova, M.L., Zubicki, A., Savu, C., Montalvan, C., Nefaa, N., Zaier, K., et al. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth. Analg. 93:5 (Nov 2001), 1111–1115.
38. [38] Shah, M., Jain, A.K., Brunelli, S.M., Coca, S.G., Devereaux, P.J., James, M.T., et al. Association between angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol., 15, Apr 2 2014, 53.
39. [39] Railton, C.J., Wolpin, J., Lam-McCulloch, J., Belo, S.E., Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can. J. Anaesth. 57:8 (Aug 2010), 736–744.
40. [40] Schulte, E., Ziegler, D., Philippi-Höhne, C., Kaczmarczyk, G., Boemke, W., Angiotensin-converting enzyme inhibition and blood pressure response during total intravenous anaesthesia for minor surgery. Acta Anaesthesiol. Scand. 55:4 (Apr 2011), 435–443.
41. [41] Goodman, S.M., Krauser, D., Mackenzie, C.R., Memtsoudis, S., Cardiac arrest during total hip arthroplasty in a patient on an angiotensin receptor antagonist. HSS J. 8:2 (Jul 2012), 175–183.
42. [42] Hohne, C., Meier, L., Boewke, W., Kaczmrczyk, G., ACE inhibition does not exaggerate the blood pressure decrease in the early phase of spinal anaesthesia. Acta Anaesthesiol. Scand. 47 (2003), 891–896.
43. [43] Castanon, E., Gutierrez, C., Fernandez, F.E., Martín, M.A., Miranda, A.F., Marí, C., Influence of angiotensin-converting enzyme inhibitors during spinal anesthesia. Rev. Esp. Anestesiol. Reanim. 42 (1995), 36–37.
44. [44] Cozanitis, D.A., The importance of interrupting angiotensin converting enzyme inhibitor treatment before spinal anaesthesia controlled case report. Anaesthesiol. Reanim. 29 (2004), 16–18.
45. [45] Pose, A., Pena, M., Baltar, A., Severe hypotension during spinal anesthesia induced by angiotensin-converting enzyme inhibitors (in Spanish). Med. Clin. (Barc), 130, 2008, 159.
46. [46] Williams, N.E., Profound bradycardia and hypotension following spinal anaesthesia in a patient receiving an ACE inhibitor: an important ‘drug' interaction?. Eur. J. Anaesthesiol. 16 (1999), 796–798.
47. [47] Akinci, S.B., Ayhan, B., Kanbak, M., Aypar, U., Refractory hypotension in a patient chronically treated with a long acting angiotensin-converting enzyme inhibitor. Anaesth. Intensive Care 32:5 (2004 Oct), 722–723.
48. [48] Trotter, J., Catecholamine-resistant hypotension following induction for spinal exploration. AANA J. 80:1 (Feb 2012), 55–60.
49. [49] Rosenman, D.J., McDonald, F.S., Ebbert, J.O., Erwin, P.J., LaBella, M., Montori, V.M., Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J. Hosp. Med. 3:4 (Jul 2008), 319–325.